ZYRTEC® Clinical Data
Powerful relief of sneezing, runny nose, and itchy nose in SAR patients1
- Improvement in Total Nasal Symptom Score (TNSS) in the first week of treatment*
- Large, multicenter study included 921 patients with seasonal allergic rhinitis; most with moderate/severe symptoms based on a 4-point scale (0=none to 3=severe)
Consistent, meaningful relief continued throughout 2-week treatment period1
- 29% to 63% mean improvement from baseline in nasal severity scores*
*Randomized, placebo-controlled studies of SAR patients (N=921). Total Nasal Symptom Score (TNSS) was the sum of the severity scores for sneezing, runny nose, itchy nose in all studies; two studies included post-nasal discharge. Individual symptom scores were rated on a 4-point scale (0=none to 3=severe).
SAR 1 was 1 week in duration.
Reference: 1. Urdaneta E, Tian X, Wu M, et al. Cetirizine effectively relieves both ocular allergy symptoms and nasal allergy symptoms in subjects with seasonal allergic rhinitis. Poster Abstract. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Health Division.
Need samples or patient resources?
More clinical data on ZYRTEC®
Here are additional clinical data on the efficacy and tolerability of ZYRTEC®
ZYRTEC® products
See the complete family of ZYRTEC® products.
